Cargando…

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study

OBJECTIVES: Non-steroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), low-dose aspirin and statins may decrease the risk of oesophageal adenocarcinoma (OAC) among patients with Barrett's oesophagus (BO). However, previous studies did not adequately address bias and confound...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masclee, Gwen M C, Coloma, Preciosa M, Spaander, Manon C W, Kuipers, Ernst J, Sturkenboom, Miriam C J M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/ https://www.ncbi.nlm.nih.gov/pubmed/25633286 http://dx.doi.org/10.1136/bmjopen-2014-006640

Ejemplares similares

Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol
por: Nieto, T, et al.
Publicado: (2016)

A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma
por: Nieto, Tom, et al.
Publicado: (2018)

Coding of Barrett’s oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study
por: Chadwick, Georgina, et al.
Publicado: (2017)

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study
por: Nieuwenburg, Stella A V, et al.
Publicado: (2019)

Diagnostic Inaccuracies of Barrett’s Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance?
por: Brosnan, Conor, et al.
Publicado: (2020)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023)

Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study
por: Mallah, Narmeen, et al.
Publicado: (2022)

Factors influencing participation in randomised clinical trials among patients with early Barrett’s neoplasia: a multicentre interview study
por: Peerally, Mohammad Farhad, et al.
Publicado: (2023)

Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study
por: Choi, Ja Sung, et al.
Publicado: (2019)

Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis
por: Jiang, Yan, et al.
Publicado: (2021)

Education level and survival after oesophageal cancer surgery: a prospective population-based cohort study
por: Brusselaers, Nele, et al.
Publicado: (2013)

Mortality in gastro-oesophageal reflux disease in a population-based nationwide cohort study of Swedish twins
por: Ness-Jensen, Eivind, et al.
Publicado: (2020)

Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses
por: Tan, JinJing, et al.
Publicado: (2020)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma
por: Luo, Yun, et al.
Publicado: (2022)

Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population
por: Hung, Wei-Chieh, et al.
Publicado: (2016)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)
por: O'Toole, Saoirse, et al.
Publicado: (2023)

Barrett’s oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review
por: Tullie, L, et al.
Publicado: (2021)

Natural History of Barrett’s Esophagus
por: Kuipers, Ernst J., et al.
Publicado: (2018)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023)

Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus
por: Cook, Michael B, et al.
Publicado: (2016)

Direct Mucosal-Side Fibrosis Cutting for Salvage Endoscopic Submucosal Dissection of Secondary Barrett's Neoplasia Adjacent Multiband Resection Scars
por: Zimmer, Vincent, et al.
Publicado: (2022)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation
por: Sattoe, Jane N T, et al.
Publicado: (2020)

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial
por: Haigh, Laura, et al.
Publicado: (2021)

Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients
por: Wan, Sizhe, et al.
Publicado: (2019)

Dietary antioxidant intake and the risk of developing Barrett’s oesophagus and oesophageal adenocarcinoma
por: Kang, James H-E, et al.
Publicado: (2018)

Computational modelling suggests that Barrett’s oesophagus may be the precursor of all oesophageal adenocarcinomas
por: Curtius, Kit, et al.
Publicado: (2021)

Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
por: Smits, L J T, et al.
Publicado: (2020)

Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial
por: Campbell, H E, et al.
Publicado: (2015)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease
por: Valery, Patricia C, et al.
Publicado: (2015)

PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial
por: Parkes, Miles, et al.
Publicado: (2018)

Effects of ileocolonic delivered vitamin B(2), B(3) and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn’s disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial
por: Otten, Antonius Timotheus, et al.
Publicado: (2023)

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial
por: Maroni, Roberta, et al.
Publicado: (2022)

Role of endoscopic ultrasonography in the diagnostic work-up of idiopathic acute pancreatitis (PICUS): study protocol for a nationwide prospective cohort study
por: Umans, Devica S, et al.
Publicado: (2020)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
por: Armstrong, Matthew J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b4f1sr8966vbio2pfuj7olif2q